Real life study of three years omalizumab in patients with difficult-to-control asthma

Even though there are multiple options for the treatment of asthma, there still exists a fair group of patients with difficult-to-control asthma. We describe for the first time the real-world effects of three-year omalizumab treatment on patients with difficult-to-control asthma, seen in a social se...

Full description

Saved in:

Bibliographic Details
Published in:	Allergologia et immunopathologia Vol. 43; no. 2; p. 120
Main Authors:	López Tiro, J Jesús, Contreras, E Angélica Contreras, del Pozo, M Elena Ramírez, Gómez Vera, J, Larenas Linnemann, D
Format:	Journal Article
Language:	English
Published:	Spain 01.03.2015
Subjects:	Adolescent Adult Aged Anti-Asthmatic Agents - therapeutic use Asthma - drug therapy Beclomethasone - therapeutic use Disease Progression Emergency Medical Services Female Humans Immunoglobulin E - immunology Male Mexico Middle Aged Omalizumab - therapeutic use Respiratory Function Tests Time Factors Young Adult Mexico Emergency room Asthmatic crisis Anti-IgE Omalizumab Biological Difficult-to-control asthma Severe asthma Asthma exacerbation Hospitalisation
ISSN:	1578-1267, 1578-1267
Online Access:	Get more information
Tags:	Add Tag No Tags, Be the first to tag this record!

Be the first to leave a comment!